FAIR ISAAC CORP
FICONYSE🏆 #626 by market capEarnings Nov 4 · PostUS Equity
$698.18▲ $6.43 (+0.93%)
Market closed · at closeTrack FICO
Get earnings, price moves & breaking news on Telegram
24h▲ 0.9%
7d▼ 15.2%
14d▼ 9.3%
30d▲ 13.1%
ytd▼ 58.7%
1y▼ 55.4%
🏦Market Cap
$15.08B
Mid Cap
📈Revenue Growth (YoY)
15.9%
Healthy
📊Gross Margin
85.1%
High
💵FCF Margin
41.6%
Strong
⚖️P/S Ratio
6.3x
Fair
Otter Score
76
Strong
FAIR ISAAC CORP
FICOAnalyst Ratings
Price
$698.18
Total
21
Raised
1
Lowered
4
Avg PT
$1070.07
H / L
$1675 / $700
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Neutral | 2026-10-26 | — | — |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2026-10-26 | $735.00 | +5.30% |
UBS | Reiterated | Neutral | 2026-10-26 | $942.00 | +34.90% |
BMO Capital | Reiterated | Outperform | 2026-10-26 | $897.00 | +28.50% |
Mizuho | Reiterated | Outperform | 2026-10-19 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-16 | $1045.00 | +49.70% |
Needham | Reiterated | Buy | 2026-10-13 | $1650.00 | +136.30% |
Raymond James | Reiterated | Outperform | 2026-10-13 | $1230.00 | +76.20% |
Baird | Reiterated | Outperform | 2026-10-02 | — | — |
Barclays | Reiterated | Overweight | 2026-10-02 | $875.00 | +25.30% |
B of A Securities | Downgraded | Buy → Neutral | 2026-09-30 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-08-03 | — | — |
Jefferies | Reiterated | Buy | 2026-05-04 | $1675.00 | +139.90% |
Goldman Sachs | Reiterated | Buy | 2026-04-02 | $1129.00 | +61.70% |
Oppenheimer | Reiterated | Outperform | 2025-07-31 | $2515.00 | +260.20% |
Deutsche Bank | Reiterated | Buy | 2023-04-28 | — | — |
Stephens & Co. | Upgraded | Equal Weight → Overweight | 2020-03-26 | — | — |
Dougherty | Reiterated | Buy | 2016-07-13 | — | — |
Sidoti & Co. | Downgraded | Buy → Neutral | 2016-03-23 | — | — |
William Blair | Reiterated | Outperform | 2016-01-26 | — | — |
Feltl & Co. | Reiterated | Buy | 2012-11-02 | — | — |
Institution
JP Morgan
Reiterated · Neutral · 2026-10-26
—
—
Wells Fargo
Downgraded · Overweight → Equal Weight · 2026-10-26
$735.00
+5.30%
UBS
Reiterated · Neutral · 2026-10-26
$942.00
+34.90%
BMO Capital
Reiterated · Outperform · 2026-10-26
$897.00
+28.50%
Mizuho
Reiterated · Outperform · 2026-10-19
—
—
RBC Capital
Reiterated · Outperform · 2026-10-16
$1045.00
+49.70%
Needham
Reiterated · Buy · 2026-10-13
$1650.00
+136.30%
Raymond James
Reiterated · Outperform · 2026-10-13
$1230.00
+76.20%
Baird
Reiterated · Outperform · 2026-10-02
—
—
Barclays
Reiterated · Overweight · 2026-10-02
$875.00
+25.30%
B of A Securities
Downgraded · Buy → Neutral · 2026-09-30
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2026-08-03
—
—
Jefferies
Reiterated · Buy · 2026-05-04
$1675.00
+139.90%
Goldman Sachs
Reiterated · Buy · 2026-04-02
$1129.00
+61.70%
Oppenheimer
Reiterated · Outperform · 2025-07-31
$2515.00
+260.20%
Deutsche Bank
Reiterated · Buy · 2023-04-28
—
—
Stephens & Co.
Upgraded · Equal Weight → Overweight · 2020-03-26
—
—
Dougherty
Reiterated · Buy · 2016-07-13
—
—
Sidoti & Co.
Downgraded · Buy → Neutral · 2016-03-23
—
—
William Blair
Reiterated · Outperform · 2016-01-26
—
—
Feltl & Co.
Reiterated · Buy · 2012-11-02
—
—
One row per institution · price target from the firm's latest published target